Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 17 November 2025
Accepted: 13 April 2026
First Online: 3 July 2026
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: EN discloses advisory board membership for Myriad Genetics and the Tourette Association of America and has received clinical trial research support from Emalex, Noema, and Octapharma Pharmaceuticals. AL discloses consulting work for Micro1.
